These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17969453)

  • 1. Viral regulation and evasion of the host response.
    Loo YM; Gale M
    Curr Top Microbiol Immunol; 2007; 316():295-313. PubMed ID: 17969453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into antiviral innate immunity revealed by studying hepatitis C virus.
    Horner SM
    Cytokine; 2015 Aug; 74(2):190-7. PubMed ID: 25819428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Bode JG; Brenndörfer ED; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):254-65. PubMed ID: 17467654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
    Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
    Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.
    Ma Y; Wang C; Xue M; Fu F; Zhang X; Li L; Yin L; Xu W; Feng L; Liu P
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity and HCV.
    Heim MH
    J Hepatol; 2013 Mar; 58(3):564-74. PubMed ID: 23063572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MxA is a positive regulator of type I IFN signaling in HCV infection.
    Shi X; Jiao B; Chen Y; Li S; Chen L
    J Med Virol; 2017 Dec; 89(12):2173-2180. PubMed ID: 28561372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
    Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
    Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
    J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic innate immunity by hepatitis C virus.
    Horner SM; Gale M
    Nat Med; 2013 Jul; 19(7):879-88. PubMed ID: 23836238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate detection of hepatitis B and C virus and viral inhibition of the response.
    Yi Z; Chen J; Kozlowski M; Yuan Z
    Cell Microbiol; 2015 Sep; 17(9):1295-303. PubMed ID: 26243406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Qi H; Chu V; Wu NC; Chen Z; Truong S; Brar G; Su SY; Du Y; Arumugaswami V; Olson CA; Chen SH; Lin CY; Wu TT; Sun R
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2018-2023. PubMed ID: 28159892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
    Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
    J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
    Yang DR; Zhu HZ
    World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    Xie Q; Chen S; Tian R; Huang X; Deng R; Xue B; Qin Y; Xu Y; Wang J; Guo M; Chen J; Tang S; Li G; Zhu H
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon signalling network in innate defence.
    Takaoka A; Yanai H
    Cell Microbiol; 2006 Jun; 8(6):907-22. PubMed ID: 16681834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
    Bruening J; Weigel B; Gerold G
    J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.